医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
24期
8-9
,共2页
恶性胸%腹水%体腔热灌注治疗%顺铂%卡铂
噁性胸%腹水%體腔熱灌註治療%順鉑%卡鉑
악성흉%복수%체강열관주치료%순박%잡박
Malignant Pleural Effusion%Malignant Abdominal Effusion%hyperthermia perfusion%CISPLATIN FOR INJECTION%CARBOPLATIN FOR INJECTION
目的体腔热灌注治疗恶性胸水腹水的疗效观察及毒副反应观察。方法共40例恶性肿瘤患者。其中12例为胸腔积液,28例为腹腔积液,均确诊为恶性胸腔积液、恶性腹腔积液。应用体腔热灌注仪器,给予体腔热灌注,应用顺铂或卡铂治疗。一般治疗3-4次,每隔4-5天一次。结果 C R:10例, P R:28例,S D:2例。结论应用体腔热灌注仪治疗恶性胸水、腹水的疗效高,局部无明显副反应,心肺功能无衰竭患者均能耐受。应用体腔热灌注仪治疗恶性胸水、腹水是可行的。
目的體腔熱灌註治療噁性胸水腹水的療效觀察及毒副反應觀察。方法共40例噁性腫瘤患者。其中12例為胸腔積液,28例為腹腔積液,均確診為噁性胸腔積液、噁性腹腔積液。應用體腔熱灌註儀器,給予體腔熱灌註,應用順鉑或卡鉑治療。一般治療3-4次,每隔4-5天一次。結果 C R:10例, P R:28例,S D:2例。結論應用體腔熱灌註儀治療噁性胸水、腹水的療效高,跼部無明顯副反應,心肺功能無衰竭患者均能耐受。應用體腔熱灌註儀治療噁性胸水、腹水是可行的。
목적체강열관주치료악성흉수복수적료효관찰급독부반응관찰。방법공40례악성종류환자。기중12례위흉강적액,28례위복강적액,균학진위악성흉강적액、악성복강적액。응용체강열관주의기,급여체강열관주,응용순박혹잡박치료。일반치료3-4차,매격4-5천일차。결과 C R:10례, P R:28례,S D:2례。결론응용체강열관주의치료악성흉수、복수적료효고,국부무명현부반응,심폐공능무쇠갈환자균능내수。응용체강열관주의치료악성흉수、복수시가행적。
Objective The treatment effect observation and toxin side effect observation Which are hyperthermia perfusion treatment Malignant have some methods. Methods There are 40 cases of patients with malignant tumors which are 12 cases of Pleural Effusion and 28 cases of Abdominal Effusion.They are al diagnosed as Malignant Pleural Effusion、Malignant Abdominal Effusion. With the apply of hyperthermia perfusion’ apparatus, perfusion medicine is rendered to the treatment of hyperthermia perfusion with CISPLATIN FOR INJECTION or CARBOPLATIN FOR INJECTION, treating 3-4per4-5days. Results The outcomes are 10 cases of CR, 24 cases of PR, 6 cases of SD. Conclusions we draw a conclusion. The treatment that the apply of hyperthermia perfusion’s apparatuses to Malignant Pleural Effusion and Malignant Abdominal Effusion is high efficacy. The patients who have no obvious side effect in the part and whose lungs and have no prostration al can use them. The apply of hyperthermia perfusion’s apparatus treating Malignant Pleural Effusion and Malignant Abdominal Effusion is feasible.